Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zucchetti

Showing results (331-340 of 479) with videos related to

Pageof 48
Sort By:
Trials|March 13, 2021
Clinical research and burnout syndrome in Italy - only a physicians' affair?Celeste Cagnazzo, Roberto Filippi, Giulia Zucchetti, et al.
Neoplasia (New York, N.Y.)|April 2, 2018
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma CellsLuca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, et al.
Transfusion|March 5, 2014
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter studyGiambattista Bertani, Luca Santoleri, Massimo Martino, et al.
Plos One|February 22, 2019
Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasisGisel S Miszczuk, Jesus M Banales, Andrés E Zucchetti, et al.
Acta Oncologica (Stockholm, Sweden)|April 3, 2019
Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvementFrancesco Fellin, Martina Iacco, Vittoria D'Avino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patientsCarlo Gambacorti-Passerini, Massimo Zucchetti, Domenico Russo, et al.
Chembiochem : a European Journal of Chemical Biology|May 2, 2018
The Photophysics of Polythiophene Nanoparticles for Biological ApplicationsIlaria Bargigia, Elena Zucchetti, Ajay Ram Srimath Kandada, et al.
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Circulation. Cardiovascular Interventions|May 17, 2022
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant RecipientsGiosafat Spitaleri, Salvatore Brugaletta, Luciano Potena, et al.
British Journal of Cancer|February 22, 2000
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicinC Corsini, M Ghielmini, P Mancuso, et al.
Pageof 48

Showing results (331-340 of 479) with videos related to

Sort By:
Pageof 48
Trials|March 13, 2021
Clinical research and burnout syndrome in Italy - only a physicians' affair?Celeste Cagnazzo, Roberto Filippi, Giulia Zucchetti, et al.
Neoplasia (New York, N.Y.)|April 2, 2018
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma CellsLuca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, et al.
Transfusion|March 5, 2014
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter studyGiambattista Bertani, Luca Santoleri, Massimo Martino, et al.
Plos One|February 22, 2019
Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasisGisel S Miszczuk, Jesus M Banales, Andrés E Zucchetti, et al.
Acta Oncologica (Stockholm, Sweden)|April 3, 2019
Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvementFrancesco Fellin, Martina Iacco, Vittoria D'Avino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patientsCarlo Gambacorti-Passerini, Massimo Zucchetti, Domenico Russo, et al.
Chembiochem : a European Journal of Chemical Biology|May 2, 2018
The Photophysics of Polythiophene Nanoparticles for Biological ApplicationsIlaria Bargigia, Elena Zucchetti, Ajay Ram Srimath Kandada, et al.
International Journal of Cancer|August 10, 2004
Dietary agent indole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compromising efficacy in a rat mammary carcinomaSarah Donald, Richard D Verschoyle, Peter Greaves, et al.
Circulation. Cardiovascular Interventions|May 17, 2022
Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant RecipientsGiosafat Spitaleri, Salvatore Brugaletta, Luciano Potena, et al.
British Journal of Cancer|February 22, 2000
Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicinC Corsini, M Ghielmini, P Mancuso, et al.
Pageof 48